Neuromyelitis optica and astrocytic damage in its pathogenesis.
about
The innate immune system in demyelinating diseaseImaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple SclerosisAn immunoassay that distinguishes real neuromyelitis optica signals from a labeling detected in patients receiving natalizumabThe use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritisInhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica.High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with the neuromyelitis optica autoantibody, NMO-IgG.Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases.Comparative Analysis for the Presence of IgG Anti-Aquaporin-1 in Patients with NMO-Spectrum Disorders.Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G.Diffusion tensor imaging of normal-appearing white matter in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.Targeting ion channels for the treatment of autoimmune neuroinflammation.Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance.The binding property of a monoclonal antibody against the extracellular domains of aquaporin-4 directs aquaporin-4 toward endocytosisDissecting the immune component of neurologic disorders: a grand challenge for the 21st century.NMO-DBr: the Brazilian Neuromyelitis Optica Database System.The single nucleotide polymorphism site of aquaporin-4 gene in patients with neuromyelitis optica.Different patterns of longitudinal brain and spinal cord changes and their associations with disability progression in NMO and MS.Spinal cord ring enhancement in patients with neuromyelitis optica.Imbalance in multiple sclerosis and neuromyelitis optica: association with deep sensation disturbance.Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica.Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease
P2860
Q24597958-AC2F3C41-F43B-4B5C-8D61-F2906E193368Q28267527-BCE80DA5-3776-4E12-93B3-2C303A37FEC9Q33895664-8A4A1D3F-3987-497A-BBFF-2CC3D9BBB1F0Q34005484-AD013908-DF80-4174-89ED-B0BC7CEB10BFQ35013113-602D6BD8-7B70-4F99-8470-8ECC3312D2C6Q36744223-AE47E890-832D-40DD-B634-294888576476Q36790810-BFBFB809-FDF4-43A2-A0D5-1C1157D1D78AQ37209820-2A48C26C-2B3C-4C37-9A8D-14168B5F7499Q37650971-BE09D82B-3DA9-4E5F-B7C9-282053E60932Q38712375-365873E1-2D3A-4D67-9428-B8B4EE66BD72Q39357037-5FAAE67F-EF34-4196-80B5-F14C543AF192Q41137046-4649395C-611E-4C7D-AFA2-6D0548133C60Q41683003-C8FE4541-C826-484C-A1C7-83D57AD9C68FQ42017702-EC059BF2-4468-4C52-A25D-66EC13C5D48BQ45918037-CAE15BC3-9741-402A-9568-290821713684Q47159383-C2D26CBE-47E7-4B12-9292-509AC94E645BQ47968702-3C0FAD08-63E0-4E78-B29E-4ABBE18FA084Q50452634-638DF154-D8E5-43E8-87C7-88BDC46A78D4Q50589607-BAAC6368-6C97-403D-B183-E712D6E0D977Q53018455-62C6D4C4-3721-4BC7-80B6-DEE8B6B6A178Q57725942-6BF8FDA5-8193-4411-9EAB-1D466FF49F59
P2860
Neuromyelitis optica and astrocytic damage in its pathogenesis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Neuromyelitis optica and astrocytic damage in its pathogenesis.
@ast
Neuromyelitis optica and astrocytic damage in its pathogenesis.
@en
type
label
Neuromyelitis optica and astrocytic damage in its pathogenesis.
@ast
Neuromyelitis optica and astrocytic damage in its pathogenesis.
@en
prefLabel
Neuromyelitis optica and astrocytic damage in its pathogenesis.
@ast
Neuromyelitis optica and astrocytic damage in its pathogenesis.
@en
P1476
Neuromyelitis optica and astrocytic damage in its pathogenesis.
@en
P2093
Kazuo Fujihara
P304
P356
10.1016/J.JNS.2011.02.018
P577
2011-03-11T00:00:00Z